Delivery Order SPE2DR25D2205-SPE2DR26F1M40
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,983.92 to AmerisourceBergen Drug Corp for VARIVAX vaccine with diluents on December 9, 2025, with a completion date of December 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was competitively awarded. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,437.12 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and was awarded on September 8, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This is a competitive award with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 10, 2025, with a ceiling value of $5,160.55 and ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $190,672.68 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on December 2, 2025, carries an ultimate completion date of December 23, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,019.65 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order was issued on November 3, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The...
- The Defense Logistics Agency awarded a $19,808.64 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 13, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract issued under a child delivery order structure. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives from AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,096.33 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under DLA's pharmaceutical procurement framework. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1M40Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,975.85 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, effective December 4, 2025, with completion targeted for December 26, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The vaccine will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a pharmaceutical prime vendor, AmerisourceBergen Drug Corp supplies critical medical commodities including vaccines, specialty medications, and medical supplies to support military healthcare programs globally. The contract serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key supplier within the federal medical supply chain for vaccine procurement and distribution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/3/25 |